{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:37:15Z","timestamp":1781545035283,"version":"3.54.5"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The inherent limitation of ocular dosage forms is decreased precorneal\nresidence time which affects the bioavailability and therapeutic efficacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The objective of the current research was to sustain drug release and enhance precorneal\ndrug residence time by formulating lipidic core-shell nanoparticles of Dexamethasone Sodium\nPhosphate and loading them in ion-sensitive in situ gel for corneal neovascularization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Polymeric nanoparticles were formulated using Eudragit L100-55 and PVA by twostep\nsolvent diffusi\u00f3n nanoprecipitation method and coated by a lipidic film of Soya phosphatidylcholine\nwith Cholesterol. The optimized lipidic core-shell nanoparticles were transformed\ninto in situ gel using Gellan gum. The lipidic core-shell nanoparticles were evaluated for particle\nsize, zeta potential, entrapment efficiency, in vitro rel\u00e9ase and in situ gel was evaluated for in\nvitro gelling time, pH, drug content, HETCAM studies, etc<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The Core-shell lipid nanoparticles exhibited a particle size of 368.00\u00b10.54 nm and zeta\npotential -13.3\u00b12.0 mV respectively. The lipidic core-shell nanoparticles were found to show a\nsustained drug release when compared to the drug solution. The optimized in situ gel was found\nto show a gelation time of 39.59\u00b12.49 seconds and was found to be non-irritant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>A decline in ex vivo drug permeation was observed through an aqueous suspension\nof core-shell polymeric nanoparticles and core-shell LPN loaded in situ gel thus confirming sustained\nrelease for the drug Dexamethasone Sodium Phosphate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113892010336099241220165806","type":"journal-article","created":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T05:55:16Z","timestamp":1748238916000},"page":"606-616","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design and Preliminary In vitro Investigation on Core Shell Nanoparticles Laden In Situ Gel for Corneal Neovascularization"],"prefix":"10.2174","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9860-066X","authenticated-orcid":true,"given":"Harita","family":"Desai","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Bombay College of Pharmacy, Kollivery Village, Mathuradas Colony, Santacruz East,Mumbai, 400098, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1057-2566","authenticated-orcid":true,"given":"Pranav","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Maliba Pharmacy College, Surat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Sawant","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Bombay College of Pharmacy, Kollivery Village, Mathuradas Colony, Santacruz East,Mumbai, 400098, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Bombay College of Pharmacy, Kollivery Village, Mathuradas Colony, Santacruz East,Mumbai, 400098, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"Gaudana R.","year":"2010","unstructured":"Gaudana R.; Ananthula H.K.; Parenky A.; Mitra A.K.; Ocular drug delivery. AAPS J  2010,12(3),348-360","journal-title":"AAPS J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/jop.1986.2.67","volume":"2","author":"Lee V.H.L.","year":"1986","unstructured":"Lee V.H.L.; Robinson J.R.; Topical ocular drug delivery: Recent developments and future challenges. J Ocul Pharmacol Ther  1986,2(1),67-108","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.22336\/rjo.2019.4","volume":"63","author":"Sharif Z.","year":"2019","unstructured":"Sharif Z.; Sharif W.; Corneal neovascularization: Updates on pathophysiology, investigations and management. Romanian J Ophthal  2019,63(1),15","journal-title":"Romanian J Ophthal"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","volume":"16","author":"Roshandel D.","year":"2018","unstructured":"Roshandel D.; Eslani M.; Rafii B.A.; Cheung A.Y.; Kurji K.; Jabbehdari S.; Maiz A.; Jalali S.; Djalilian A.R.; Holland E.J.; Current and emerging therapies for corneal neovascularization. Ocul Surf  2018,16(4),398-414","journal-title":"Ocul Surf"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/B978-0-323-35775-3.00021-7","author":"Labelle P.","year":"2017","unstructured":"Labelle P.;  The Eye1Pathologic Basis of Veterinary Disease  2017,1265-1318.e1","journal-title":"The Eye1Pathologic Basis of Veterinary Disease"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5497\/wjp.v2.i2.47","volume":"2","author":"Patel A.","year":"2013","unstructured":"Patel A.; Ocular drug delivery systems: An overview. World J Pharmacol  2013,2(2),47","journal-title":"World J Pharmacol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40662-017-0094-6","volume":"4","author":"Feizi S.","year":"2017","unstructured":"Feizi S.; Azari A.A.; Safapour S.; Therapeutic approaches for corneal neovascularization. Eye Vision  2017,4(1),28","journal-title":"Eye Vision"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.oftal.2013.07.010","volume":"89","author":"Schargel K.","year":"2014","unstructured":"Schargel K.; Review of books and audiovisual media. Arch Soc Esp Oftalmol  2014,89(2),e9","journal-title":"Arch Soc Esp Oftalmol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","volume":"12","author":"Chang J.H.","year":"2001","unstructured":"Chang J.H.; Gabison E.E.; Kato T.; Azar D.T.; Corneal neovascularization. Curr Opin Ophthalmol  2001,12(4),242-249","journal-title":"Curr Opin Ophthalmol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ophtha.2011.01.041","volume":"118","author":"Maddula S.","year":"2011","unstructured":"Maddula S.; Davis D.K.; Maddula S.; Burrow M.K.; Ambati B.K.; Horizons in therapy for corneal angiogenesis. Ophthalmology  2011,118(3),591-599","journal-title":"Ophthalmology"},{"key":"ref=11","first-page":"288","volume":"89","author":"Irvine S.R.","year":"1951","unstructured":"Irvine S.R.; Irvine M.D.; Kastner C.B.; The effect of cortisone on the primary secondary aqueous and on corneal vascularization in rabbits. Bull Johns Hopkins Hosp  1951,89(4),288-302","journal-title":"Bull Johns Hopkins Hosp"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0022-3565(25)22251-0","volume":"250","author":"Schleimer R.P.","year":"1989","unstructured":"Schleimer R.P.; Freeland H.S.; Peters S.P.; Brown K.E.; Derse C.P.; An assessment of the effects of glucocorticoids on degranulation, chemotaxis, binding to vascular endothelium and formation of leukotriene B4 by purified human neutrophils. J Pharmacol Exp Ther  1989,250(2),598-605","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.ophtha.2010.01.039","volume":"117","author":"Bachmann B.","year":"2010","unstructured":"Bachmann B.; Taylor R.S.; Cursiefen C.; Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty. Ophthalmology  2010,117(7),1300-1305.e7","journal-title":"Ophthalmology"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajps.2018.04.008","volume":"14","author":"Wu Y.","year":"2019","unstructured":"Wu Y.; Liu Y.; Li X.; Kebebe D.; Zhang B.; Ren J.; Lu J.; Li J.; Du S.; Liu Z.; Research progress of in-situ gelling ophthalmic drug delivery system. Asian J Pharm Sci  2019,14(1),1-15","journal-title":"Asian J Pharm Sci"},{"key":"ref=15","doi-asserted-by":"publisher","DOI":"10.1016\/j.matpr.2023.07.161","author":"Ahirrao S.P.","year":"2023","unstructured":"Ahirrao S.P.; Bhambere D.S.; Agiwale B.; Algat S.; Zoman D.; Chaudhari V.; pH sensitive in-situ gel for ophthalmic delivery of ofloxacin and dexamethasone sodium phosphate: Formulation, development, and evaluation. Materials Today Proceedings  2023","journal-title":"Materials Today Proceedings"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.37285\/ijpsn.2018.11.5.8","volume":"11","author":"Patel V.P.","year":"2018","unstructured":"Patel V.P.; Pande V.V.; Design P.V.K.; Development and evaluation of dexamethasone sodium phosphate niosomal in-situ gel for visual medication conveyance. Int J Pharm Sci Nanotechnol  2018,11(5),4274-4279","journal-title":"Int J Pharm Sci Nanotechnol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.addr.2018.07.008","volume":"130","author":"Chen G.","year":"2018","unstructured":"Chen G.; Wang Y.; Xie R.; Gong S.; A review on core\u2013shell structured unimolecular nanoparticles for biomedical applications. Adv Drug Deliv Rev  2018,130,58-72","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.addr.2016.04.001","volume":"106","author":"Niu Z.","year":"2016","unstructured":"Niu Z.; S\u00e1nchez C.I.; Griffin B.T.; O\u2019Driscoll C.M.; Alonso M.J.; Lipid-based nanocarriers for oral peptide delivery. Adv Drug Deliv Rev  2016,106(Pt B),337-354","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"645","DOI":"10.4155\/tde.12.38","volume":"3","author":"Heneweer C.","year":"2012","unstructured":"Heneweer C.; Gendy S.E.M.; Medina P.O.; Liposomes and inorganic nanoparticles for drug delivery and cancer imaging. Ther Deliv  2012,3(5),645-656","journal-title":"Ther Deliv"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/archophthalmol.2011.42","volume":"129","author":"Hos D.","year":"2011","unstructured":"Hos D.; Saban D.R.; Bock F.; Regenfuss B.; Onderka J.; Masli S.; Cursiefen C.; Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids. Arch Ophthalmol  2011,129(4),445-452","journal-title":"Arch Ophthalmol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijpharm.2010.05.008","volume":"395","author":"Liu Y.","year":"2010","unstructured":"Liu Y.; Pan J.; Feng S.S.; Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: Effects of surfactants on particles size, characteristics and in vitro performance. Int J Pharm  2010,395(1-2),243-250","journal-title":"Int J Pharm"},{"key":"ref=22","first-page":"001","volume":"27","author":"Turk S.C.T.","year":"2023","unstructured":"Turk S.C.T.; Core shell type lipid polymer hybrid nanocarriers as a novel-generation drug delivery platform. J Res Pharm  2023,27,001-003","journal-title":"J Res Pharm"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2018024751","volume":"35","author":"Jose C.","year":"2018","unstructured":"Jose C.; Amra K.; Bhavsar C.; Momin M.; Omri A.; Polymeric lipid hybrid nanoparticles: Properties and therapeutic applications. Crit Rev Ther Drug Carrier Syst  2018,35(6),555-588","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"593878","DOI":"10.1155\/2012\/593878","volume":"2012","author":"Manaspon C.","year":"2012","unstructured":"Manaspon C.; Pasuwat V.K.; Pimpha N.; Preparation of folate-conjugated pluronic F127\/Chitosan core-shell nanoparticles encapsulating doxorubicin for breast cancer treatment. J Nanomater  2012,2012(1),593878","journal-title":"J Nanomater"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1208\/s12249-011-9675-1","volume":"12","author":"Bhagav P.","year":"2011","unstructured":"Bhagav P.; Upadhyay H.; Chandran S.; Brimonidine tartrate-eudragit long-acting nanoparticles: Formulation, optimization, in vitro and in vivo evaluation. AAPS PharmSciTech  2011,12(4),1087-1101","journal-title":"AAPS PharmSciTech"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3390\/nano7060122","volume":"7","author":"Li Q.","year":"2017","unstructured":"Li Q.; Cai T.; Huang Y.; Xia X.; Cole S.; Cai Y.; A review of the structure, preparation, and application of NLCs, PNPs, and PLNs. Nanomaterials  2017,7(6),122","journal-title":"Nanomaterials"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/02713680903017500","volume":"34","author":"Attama A.A.","year":"2009","unstructured":"Attama A.A.; Reichl S.; Goymann M.C.C.; Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea. Curr Eye Res  2009,34(8),698-705","journal-title":"Curr Eye Res"},{"key":"ref=28","first-page":"24","volume":"12","author":"Budumuru P.","year":"2020","unstructured":"Budumuru P.; Nagaraju R.; Damarasingu P.; A comprehensive review on in situ gels. Int J Appl Pharm  2020,12,24-33","journal-title":"Int J Appl Pharm"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"12368","DOI":"10.3390\/ijms222212368","volume":"22","author":"Vaneev A.","year":"2021","unstructured":"Vaneev A.; Tikhomirova V.; Chesnokova N.; Popova E.; Beznos O.; Kost O.; Klyachko N.; Nanotechnology for topical drug delivery to the anterior segment of the eye. Int J Mol Sci  2021,22(22),12368","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/pharmaceutics13040533","volume":"13","author":"Rodr\u00edguez P.E.","year":"2021","unstructured":"Rodr\u00edguez P.E.; Reinares L.M.; Ventosa M.A.; Torras P.S.; Campos F.F.; Dexamethasone-loaded lipomers: Development, characterization, and skin biodistribution studies. Pharmaceutics  2021,13(4),533","journal-title":"Pharmaceutics"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nano.2009.09.002","volume":"6","author":"Das S.","year":"2010","unstructured":"Das S.; Suresh P.K.; Desmukh R.; Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine  2010,6(2),318-323","journal-title":"Nanomedicine"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/1735-5362.199041","volume":"12","author":"Jelvehgari M.","year":"2017","unstructured":"Jelvehgari M.; Salatin S.; Barar J.; Jalali B.M.; Adibkia K.; Kiafar F.; Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles. Res Pharm Sci  2017,12(1),1-14","journal-title":"Res Pharm Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0928-0987(02)00057-X","volume":"16","author":"Pignatello R.","year":"2002","unstructured":"Pignatello R.; Bucolo C.; Ferrara P.; Maltese A.; Puleo A.; Puglisi G.; Eudragit RS100\u00ae nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci  2002,16(1-2),53-61","journal-title":"Eur J Pharm Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0169-409X(95)00017-2","volume":"16","author":"Zimmer A.","year":"1995","unstructured":"Zimmer A.; Kreuter J.; Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev  1995,16(1),61-73","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=35","first-page":"4313","volume":"12","author":"Akb S.","year":"2017","unstructured":"Akb S.; Mahmood S.; Tan I.; Adeyemi J.; Evaluation of one factor at a time (OFAT) technique in viscosity modeling of polymer solution. J Eng Appl Sci  2017,12,4313-4319","journal-title":"J Eng Appl Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ajps.2015.09.004","volume":"11","author":"Sharma N.","year":"2016","unstructured":"Sharma N.; Madan P.; Lin S.; Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: A co-surfactant study. Asian J Pharm Sci  2016,11(3),404-416","journal-title":"Asian J Pharm Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"358","DOI":"10.4103\/1735-5362.319574","volume":"16","author":"Rezazadeh M.","year":"2021","unstructured":"Rezazadeh M.; Safaran R.; Minaiyan M.; Mostafavi A.; Preparation and characterization of Eudragit L 100-55\/chitosan enteric nanoparticles containing omeprazole using general factorial design. Res Pharm Sci  2021,16(4),358-369","journal-title":"Res Pharm Sci"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"5067","DOI":"10.2147\/IJN.S117511","volume":"11","author":"Rajinikanth P.","year":"2016","unstructured":"Rajinikanth P.; Chellian J.; Development and evaluation of nanostructured lipid carrier-based hydrogel for topical delivery of 5-fluorouracil. Int J Nanomedicine  2016,11,5067-5077","journal-title":"Int J Nanomedicine"},{"key":"ref=39","first-page":"117","volume":"5","author":"Lin Y.K.","year":"2010","unstructured":"Lin Y.K.; Huang Z.R.; Zhuo R.Z.; Fang J.Y.; Combination of calcipotriol and methotrexate in nanostructured lipid carriers for topical delivery. Int J Nanomedicine  2010,5(Feb),117-128","journal-title":"Int J Nanomedicine"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2147\/IJN.S44487","volume":"8","author":"Qi J.","year":"2013","unstructured":"Qi J.; Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): In vitro characterization and improved corneal permeation. Int J Nanomedicine  2013,8,1921-1933","journal-title":"Int J Nanomedicine"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.4103\/kleuhsj.kleuhsj_131_17","volume":"10","author":"Dasankoppa F.","year":"2017","unstructured":"Dasankoppa F.; Solankiy P.; Sholapur H.; Jamakandi V.G.; Sajjanar V.M.; Walveka P.M.; Design, formulation, and evaluation of in situ gelling ophthalmic drug delivery system comprising anionic and nonionic polymers. Indian J Health Sci Biomed Res  2017,10(3),323-330","journal-title":"Indian J Health Sci Biomed Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1194\/jlr.D010959","volume":"52","author":"Zhang L.","year":"2011","unstructured":"Zhang L.; Song J.; Cavigiolio G.; Ishida B.Y.; Zhang S.; Kane J.P.; Weisgraber K.H.; Oda M.N.; Rye K.A.; Pownall H.J.; Ren G.; Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy. J Lipid Res  2011,52(1),175-184","journal-title":"J Lipid Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/2231-4040.107495","volume":"4","author":"Kumar D.","year":"2013","unstructured":"Kumar D.; Jain N.; Gulati N.; Nagaich U.; Nanoparticles laden in situ gelling system for ocular drug targeting. J Adv Pharm Technol Res  2013,4(1),9-17","journal-title":"J Adv Pharm Technol Res"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijpharm.2018.11.016","volume":"554","author":"Ranch K.M.","year":"2019","unstructured":"Ranch K.M.; Maulvi F.A.; Naik M.J.; Koli A.R.; Parikh R.K.; Shah D.O.; Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies. Int J Pharm  2019,554,264-275","journal-title":"Int J Pharm"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"281","DOI":"10.34172\/bi.2021.10","volume":"11","author":"Rahimzadeh G.","year":"2020","unstructured":"Rahimzadeh G.; Saeedi M.; Nokhodchi A.; Moosazadeh M.; Ghasemi M.; Rostamkalaei S.S.; Mortazavi P.; Eghbali M.; Pourbakhshian R.; Rezai M.S.; Hevelaee N.E.; Evaluation of in-situ gel-forming eye drop containing bacteriophage against Pseudomonas aeruginosa keratoconjunctivitis in vivo. Bioimpacts  2020,11(4),281-287","journal-title":"Bioimpacts"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/10717540701606426","volume":"14","author":"Gupta H.","year":"2007","unstructured":"Gupta H.; Jain S.; Mathur R.; Mishra P.; Mishra A.K.; Velpandian T.; Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv  2007,14(8),507-515","journal-title":"Drug Deliv"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ejps.2014.07.013","volume":"63","author":"Okur \u00dc.N.","year":"2014","unstructured":"Okur \u00dc.N.; G\u00f6k\u00e7e E.H.; Bozb\u0131y\u0131k D.\u0130.; E\u011frilmez S.; \u00d6zer \u00d6.; Ertan G.; Preparation and in vitro\u2013in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis. Eur J Pharm Sci  2014,63,204-215","journal-title":"Eur J Pharm Sci"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.nano.2012.11.010","volume":"9","author":"Mandal B.","year":"2013","unstructured":"Mandal B.; Core\u2013shell-type lipid\u2013polymer hybrid nanoparticles as a drug delivery platform. Nanomedicine  2013,9(4),474-491","journal-title":"Nanomedicine"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"E12","DOI":"10.1208\/pt070357","volume":"7","author":"Rathore M.S.","year":"2006","unstructured":"Rathore M.S.; Majumdar D.K.; Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops. AAPS PharmSciTech  2006,7(3),E12-E17","journal-title":"AAPS PharmSciTech"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jconrel.2018.03.003","volume":"276","author":"Bao Q.","year":"2018","unstructured":"Bao Q.; Newman B.; Wang Y.; Choi S.; Burgess D.J.; In vitro and ex vivo correlation of drug release from ophthalmic ointments. J Control Release  2018,276,93-101","journal-title":"J Control Release"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.3390\/polym15214336","volume":"15","author":"Aldawsari M.F.","year":"2023","unstructured":"Aldawsari M.F.; Moglad E.H.; Alotaibi H.F.; Alkahtani H.M.; Khafagy E.S.; Ophthalmic bimatoprost-loaded niosomal in situ gel: Preparation, optimization, and in vivo pharmacodynamics study. Polymers  2023,15(21),4336","journal-title":"Polymers"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/2230-973X.160850","volume":"5","author":"Kumar P.","year":"2015","unstructured":"Kumar P.; Singh S.; Mishra D.; Girotra P.; Enhancement of ketorolac tromethamine permeability through rat skin using penetration enhancers: An ex-vivo study. Int J Pharm Investig  2015,5(3),142-146","journal-title":"Int J Pharm Investig"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/15569520601183815","volume":"26","author":"Yan X.","year":"2007","unstructured":"Yan X.; Piterski C.; Nitka S.; Evaluation of the hen\u2019s egg test-chorioallantonic membrane (CAM) method in prediction of the eye irritation potential formulated personal wash products. Cutan Ocul Toxicol  2007,26(1),25-36","journal-title":"Cutan Ocul Toxicol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3390\/cancers14061476","volume":"14","author":"Pizon M.","year":"2022","unstructured":"Pizon M.; Schott D.; Pachmann U.; Schobert R.; Pizon M.; Wozniak M.; Bobinski R.; Pachmann K.; Chick chorioallantoic membrane (CAM) assays as a model of patient-derived xenografts from circulating cancer stem cells (cCSCs) in breast cancer patients. Cancers  2022,14(6),1476","journal-title":"Cancers"},{"key":"ref=55","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acsmaterialsau.3c00032","volume":"3","author":"Mehta M.","year":"2023","unstructured":"Mehta M.; Bui T.A.; Yang X.; Aksoy Y.; Goldys E.M.; Deng W.; Lipid-based nanoparticles for Drug\/Gene delivery: An overview of the production techniques and difficulties encountered in their industrial development. ACS Mater Au  2023,3(6),600-619","journal-title":"ACS Mater Au"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1002\/jps.21148","volume":"97","author":"He W.","year":"2008","unstructured":"He W.; Jiang X.; Zhang Z.R.; Preparation and evaluation of poly-butylcyanoacrylate nanoparticles for oral delivery of thymopentin. J Pharm Sci  2008,97(6),2250-2259","journal-title":"J Pharm Sci"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"27835","DOI":"10.1039\/D0RA04971A","volume":"10","author":"Gorantla S.","year":"2020","unstructured":"Gorantla S.; Rapalli V.K.; Waghule T.; Singh P.P.; Dubey S.K.; Saha R.N.; Singhvi G.; Nanocarriers for ocular drug delivery: Current status and translational opportunity. RSC Advances  2020,10(46),27835-27855","journal-title":"RSC Advances"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1208\/s12249-023-02516-9","volume":"24","author":"Ahmed S.","year":"2023","unstructured":"Ahmed S.; Amin M.M.; Sayed S.; Ocular drug delivery: A comprehensive review. AAPS PharmSciTech  2023,24(2),66","journal-title":"AAPS PharmSciTech"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.22159\/ajpcr.2022.v15i9.45302","volume":"15","author":"Desai M.","year":"2022","unstructured":"Desai M.; Kapadia J.; Factors affecting intraocular bioavailability of drugs. Asian J Pharm Clin Res  2022,15(9),15-24","journal-title":"Asian J Pharm Clin Res"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/jbm.b.10046","volume":"66B","author":"Zweers M.L.T.","year":"2003","unstructured":"Zweers M.L.T.; Grijpma D.W.; Engbers G.H.M.; Feijen J.; The preparation of monodisperse biodegradable polyester nanoparticles with a controlled size. J Biomed Mater Res B Appl Biomater  2003,66B(2),559-566","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"8040","DOI":"10.1021\/acs.macromol.2c00907","volume":"55","author":"Bovone G.","year":"2022","unstructured":"Bovone G.; Cousin L.; Steiner F.; Tibbitt M.W.; Solvent controls nanoparticle size during nanoprecipitation by limiting block copolymer assembly. Macromolecules  2022,55(18),8040-8048","journal-title":"Macromolecules"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.3390\/app13137820","volume":"13","author":"Rascon C.","year":"2023","unstructured":"Rascon C.; Pineda F.G.; Target selection strategies for demucs-based speech enhancement. Appl Sci  2023,13(13),7820","journal-title":"Appl Sci"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"593","DOI":"10.15171\/apb.2019.068","volume":"9","author":"Mohammadi G.","year":"2019","unstructured":"Mohammadi G.; Mirzaeei S.; Taghe S.; Mohammadi P.; Delivery. Adv Pharm Bull  2019,9(4),593-600","journal-title":"Adv Pharm Bull"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.cclet.2019.04.048","volume":"31","author":"Zhou Y.","year":"2020","unstructured":"Zhou Y.; Fang A.; Wang F.; Li H.; Jin Q.; Huang L.; Song X.; Core-shell lipid-polymer nanoparticles as a promising ocular drug delivery system to treat glaucoma. Chin Chem Lett  2020,31(2),494-500","journal-title":"Chin Chem Lett"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"580118","DOI":"10.3389\/fchem.2021.580118","volume":"9","author":"Dhiman N.","year":"2021","unstructured":"Dhiman N.; Awasthi R.; Sharma B.; Kharkwal H.; Kulkarni G.T.; Lipid nanoparticles as carriers for bioactive delivery. Front Chem  2021,9,580118","journal-title":"Front Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3109\/10717544.2014.919543","volume":"23","author":"Huang Z.","year":"2016","unstructured":"Huang Z.; Yang W.; Zong Y.; Qiu S.; Chen X.; Sun X.; Zhou Y.; Xie Z.; Gao Q.; A study of the dexamethasone sodium phosphate release properties from a periocular capsular drug delivery system. Drug Deliv  2016,23(3),839-847","journal-title":"Drug Deliv"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e20126","DOI":"10.17795\/jjnpp-20126","volume":"9","author":"Kouchak M.","year":"2014","unstructured":"Kouchak M.; In situ gelling systems for drug delivery. Jundishapur J Nat Pharm Prod  2014,9(3),e20126","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3390\/pharmaceutics12090859","volume":"12","author":"Vigani B.","year":"2020","unstructured":"Vigani B.; Rossi S.; Sandri G.; Bonferoni M.C.; Caramella C.M.; Ferrari F.; Recent advances in the development of in situ gelling drug delivery systems for non-parenteral administration routes. Pharmaceutics  2020,12(9),859","journal-title":"Pharmaceutics"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"100156","DOI":"10.1016\/j.fhfh.2023.100156","volume":"4","author":"Giri S.","year":"2023","unstructured":"Giri S.; Markandeywar T.S.; Irfan Z.; Manna S.; Gellan gum and sodium alginate in-situ gel of monocaprin for effective corneal permeation. Food Hydr Health  2023,4,100156","journal-title":"Food Hydr Health"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1007\/s13346-022-01155-0","volume":"12","author":"Khare P.","year":"2022","unstructured":"Khare P.; Chogale M.M.; Kakade P.; Patravale V.B.; Gellan gum\u2013based in situ gelling ophthalmic nanosuspension of Posaconazole. Drug Deliv Transl Res  2022,12(12),2920-2935","journal-title":"Drug Deliv Transl Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2185180","DOI":"10.1080\/10717544.2023.2185180","volume":"30","author":"Kalaria V.J.","year":"2023","unstructured":"Kalaria V.J.; Saisivam S.; Alshishani A.; Alhesan A.J.S.; Chakraborty S.; Rahamathulla M.; Design and evaluation of in situ gel eye drops containing nanoparticles of Gemifloxacin Mesylate. Drug Deliv  2023,30(1),2185180","journal-title":"Drug Deliv"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/pharmaceutics13081291","volume":"13","author":"Sivadasan D.","year":"2021","unstructured":"Sivadasan D.; Sultan M.H.; Madkhali O.; Almoshari Y.; Thangavel N.; Polymeric lipid hybrid nanoparticles (PLNs) as emerging drug delivery platform\u2014A comprehensive review of their properties, preparation methods, and therapeutic applications. Pharmaceutics  2021,13(8),1291","journal-title":"Pharmaceutics"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/1091581816672187","volume":"35","author":"Duharte B.A.","year":"2016","unstructured":"Duharte B.A.; Murillo J.G.; P\u00e9rez U.M.; Tur E.N.; Portuondo D.F.; Mart\u00ednez B.T.; Mart\u00ednez T.D.; Betancourt J.E.; P\u00e9rez O.; The hen\u2019s egg test on chorioallantoic membrane. Int J Toxicol  2016,35(6),627-633","journal-title":"Int J Toxicol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"105255","DOI":"10.1016\/j.tiv.2021.105255","volume":"78","author":"Viera A.L.L.M.","year":"2022","unstructured":"Viera A.L.L.M.; Silva R.S.; Silva d.C.C.; Presgrave O.A.F.; Boas M.H.S.V.; Comparison of the different protocols of the Hen\u2019s Egg Test-Chorioallantoic Membrane (HET-CAM) by evaluating the eye irritation potential of surfactants. Toxicol In Vitro  2022,78,105255","journal-title":"Toxicol In Vitro"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"8","DOI":"10.9734\/jpri\/2021\/v33i40A32215","volume":"33","author":"Aher S.","year":"2021","unstructured":"Aher S.; Singh R.P.; Kumar M.; Preparation and characterization of nano structured lipid carriers for ocular bacterial infection. J Pharm Res Int  2021,33(40A),8-23","journal-title":"J Pharm Res Int"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010336099241220165806","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/242268\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010336099241220165806","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:56:28Z","timestamp":1781510188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/242268\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010336099241220165806","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}